Press Releases

News

All in the Timing: Hour of Radiation Treatments Can Affect Mucositis for Patients With Head/Neck Cancers

Painful sores in the mouth and throat are one of the most common adverse side effects caused by radiation therapy, which is a mainstay of treatment for most cancers of the head and neck. This condition, known as oral mucositis, frequently causes quality-of-life issues such as difficulty swallowing or eating and interrupted sleep, and often necessitates prescription of opioids or other analgesics for pain control. New research from Roswell Park Comprehensive Cancer Center, to be presented at the American Association for Cancer Research (AACR) Annual Meeting 2019 in Atlanta, reports that administering radiation treatments in the morning as opposed to later in the day can significantly reduce severity of mucositis and its related impacts.
News

With Safety Analysis Now Complete, Roswell Park Moves Forward With Expanded Study of CIMAvax

Final results from the first U.S. clinical study of a Cuban immunotherapy show that CIMAvax-EGF, a treatment targeting a particular cancer survival protein, epidermal growth factor (EGF), is safe and showed promising efficacy as part of a treatment combination with nivolumab (Opdivo) in patients with advanced non-small cell lung cancer (NSCLC). Principal Investigator Grace Dy, MD, will share these findings in a presentation at the American Association for Cancer Research (AACR) Annual Meeting 2019 in Atlanta.
News

Roswell Park Researchers Take Center Stage at Meeting of Experts on Gynecologic Cancers

Members of Roswell Park Comprehensive Cancer Center’s senior leadership team, physician staff and fellows have been invited to present research findings and insights at the Society of Gynecologic Oncology (SGO) 50th Annual Meeting on Women’s Cancer. SGO is considered the premier specialty society for healthcare professionals focused on comprehensive treatment of gynecological cancers. The meeting runs March 16-19 in Honolulu, Hawaii.

Dr. Song Yao
News

Roswell Park Attracts $28.2M in Grants, Including $9.7M for Studies of Breast Cancer in African-Americans

A $6.6 million award from the National Cancer Institute (NCI) leads the latest slew of grants awarded to Roswell Park Comprehensive Cancer Center researchers. These awards totaling more than $28.2 million in new funding from federal agencies as well as nonprofit foundations and associations will enable critical investigations to help explain why an aggressive form of breast cancer is more common in African-American women, learn how cancer metastasizes and develops resistance to treatment, explore opportunities to enhance patients’ recovery following surgery and advance development of a pioneering immunotherapy involving engineered T cells.